Keyphrases
Atherosclerotic Cardiovascular Disease (ASCVD)
100%
Remnant Cholesterol
77%
Myocardial Infarction
67%
Homozygous Familial Hypercholesterolemia (HoFH)
51%
Ischemic Heart Disease
41%
C-reactive Protein
34%
Cardiovascular Outcomes
28%
Cholesterol Levels
27%
Cardiovascular Mortality
25%
Trial Design
25%
Gene Variants
25%
Proprotein Convertase Subtilisin Kexin Type 9 (PCSK9)
25%
Ergometrine
25%
Low-density Lipoprotein Receptor
25%
High-density Lipoprotein Cholesterol (HDL-C)
25%
High Incidence
25%
East Europeans
25%
Triglyceride-rich Lipoproteins
25%
REDUCE-IT
25%
East Asia
25%
Risk Estimation
25%
Ultra-high Risk
25%
Right Coronary Artery
25%
Saphenous Vein Graft
25%
Coronary Artery Spasm
25%
Provocation Test
25%
Reclassification
21%
Lipoproteins
19%
Copenhagen
17%
General Population Studies
17%
Acute Coronary Syndrome
17%
Hazard Ratio
16%
Myocardial Ischemia
14%
All-cause Mortality
12%
From below
11%
Secondary Prevention
9%
High Risk
9%
Low-density Lipoprotein Cholesterol (LDL-C)
9%
Eicosapentaenoic Acid
8%
Net Reclassification Index
8%
Difficulty Level
8%
Beginner
8%
Coronary Artery Bypass Grafting
8%
Pharmacological Assays
8%
Possible Causes
8%
Low-density Lipoprotein Receptor Gene
7%
Primary Prevention
6%
World Regions
6%
East Asian Population
6%
Low-grade Inflammation
6%
Pharmacology, Toxicology and Pharmaceutical Science
Coronary Artery Atherosclerosis
85%
Heart Infarction
51%
C Reactive Protein
41%
Ischemic Heart Disease
28%
Population Study
26%
Familial Hypercholesterolemia
25%
Cohort Study
25%
Cardiovascular Mortality
25%
Lipoprotein
25%
Icosapentaenoic Acid
15%
All Cause Mortality
12%
Cardiovascular Risk
10%
Mineral Oil
10%
Omega-3 Fatty Acid
10%
Statin (Protein)
7%
Low Density Lipoprotein Cholesterol
7%
Inflammation
6%
Biological Marker
5%
Atherosclerosis
5%
Docosahexaenoic Acid
5%
Intervention Trial
5%
Morbidity
5%
Maize
5%
Triacylglycerol
5%
Hypertriglyceridemia
5%
Icosapentaenoic Acid Ethyl Ester
5%
Biochemistry, Genetics and Molecular Biology
Familial Hypercholesterolemia
51%
C-Reactive Protein
44%
Population
35%
Population Research
35%
Cholesterol Level
25%
Cohort Study
25%
LDL Receptor
25%
Proprotein Convertase
19%
Subtilisin
19%
Kexin
19%
Eicosapentaenoic Acid
19%
Lipid
15%
All Cause Mortality
14%
Low-Density Lipoprotein
13%
Statin
12%
Genetics
8%
Receptor Gene
8%
Omega-3 Fatty Acid
6%
Risk Reduction
6%
Intervention Trial
6%
Docosahexaenoic Acid
6%
Morbidity
6%
Hypertriglyceridemia
6%
Drug Megadose
6%
Triacylglycerol Blood Level
6%
